Literature DB >> 26790861

A Qualitative Exploration of a Clinical Ethicist's Role and Contributions During Family Meetings.

Courtenay R Bruce1,2, Trevor M Bibler3,4, Adam M Pena3,4, Betsy Kusin3,4.   

Abstract

Despite the interpersonal nature of family meetings and the frequency in which they occur, the clinical ethics literature is devoid of any rich descriptions of what clinical ethicists should actually be doing during family meetings. Here, we propose a framework for describing and understanding "transitioning" facilitation skills based on a retrospective review of our internal documentation of 100 consecutive cases (June 01, 2013-December 31, 2014) wherein a clinical ethicist facilitated at least one family meeting. The internal documents were analyzed using qualitative methodologies, i.e., "codes", to identify emergent themes. We identified four different transitioning strategies clinical ethicists use to reach a meaningful resolution. These transitioning strategies serve as a jumping-off point for additional analyses, future research, evaluating clinical ethics consultation, and overall performance improvement of a consultation service.

Keywords:  Clinical ethics consultation; Communication; Decision-making; Facilitation; Family meetings

Mesh:

Year:  2016        PMID: 26790861     DOI: 10.1007/s10730-015-9300-x

Source DB:  PubMed          Journal:  HEC Forum        ISSN: 0956-2737


  12 in total

Review 1.  Whatever happened to qualitative description?

Authors:  M Sandelowski
Journal:  Res Nurs Health       Date:  2000-08       Impact factor: 2.228

2.  Studying communication about end-of-life care during the ICU family conference: development of a framework.

Authors:  J Randall Curtis; Ruth A Engelberg; Marjorie D Wenrich; Elizabeth L Nielsen; Sarah E Shannon; Patsy D Treece; Mark R Tonelli; Donald L Patrick; Lynne S Robins; Barbara B McGrath; Gordon D Rubenfeld
Journal:  J Crit Care       Date:  2002-09       Impact factor: 3.425

3.  I don't want to be the one saying 'we should just let him die': intrapersonal tensions experienced by surrogate decision makers in the ICU.

Authors:  Yael Schenker; Megan Crowley-Matoka; Daniel Dohan; Greer A Tiver; Robert M Arnold; Douglas B White
Journal:  J Gen Intern Med       Date:  2012-07-28       Impact factor: 5.128

4.  Why quality is addressed so rarely in clinical ethics consultation.

Authors:  George J Agich
Journal:  Camb Q Healthc Ethics       Date:  2009       Impact factor: 1.284

5.  Practical guidance for charting ethics consultations.

Authors:  Courtenay R Bruce; Martin L Smith; Olubukunola Mary Tawose; Richard R Sharp
Journal:  HEC Forum       Date:  2014-03

6.  A systematic review of activities at a high-volume ethics consultation service.

Authors:  Courtenay R Bruce; Martin L Smith; Sabahat Hizlan; Richard R Sharp
Journal:  J Clin Ethics       Date:  2011

7.  Surrogate decision makers' interpretation of prognostic information: a mixed-methods study.

Authors:  Lucas S Zier; Peter D Sottile; Seo Yeon Hong; Lisa A Weissfield; Douglas B White
Journal:  Ann Intern Med       Date:  2012-03-06       Impact factor: 25.391

8.  A communication strategy and brochure for relatives of patients dying in the ICU.

Authors:  Alexandre Lautrette; Michael Darmon; Bruno Megarbane; Luc Marie Joly; Sylvie Chevret; Christophe Adrie; Didier Barnoud; Gérard Bleichner; Cédric Bruel; Gérald Choukroun; J Randall Curtis; Fabienne Fieux; Richard Galliot; Maité Garrouste-Orgeas; Hugues Georges; Dany Goldgran-Toledano; Mercé Jourdain; Georges Loubert; Jean Reignier; Fayçal Saidi; Bertrand Souweine; François Vincent; Nancy Kentish Barnes; Frédéric Pochard; Benoit Schlemmer; Elie Azoulay
Journal:  N Engl J Med       Date:  2007-02-01       Impact factor: 91.245

Review 9.  Practical guidance for evidence-based ICU family conferences.

Authors:  J Randall Curtis; Douglas B White
Journal:  Chest       Date:  2008-10       Impact factor: 9.410

10.  Qualitative description - the poor cousin of health research?

Authors:  Mette Asbjoern Neergaard; Frede Olesen; Rikke Sand Andersen; Jens Sondergaard
Journal:  BMC Med Res Methodol       Date:  2009-07-16       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.